Global Immunotherapy in Oncology Startup Identification Report 2020: Over 110 Startups Working in the Field of Onco-Immunotherapy

Advertisement

BEGIN ARTICLE PREVIEW:

Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) — The “Immunotherapy in Oncology Startup Identification” report has been added to ResearchAndMarkets.com’s offering. Cancer Immunotherapy is a very dynamic technological field and the global market is expected to grow and reach US$ 126.9 billion by 2026, with a CAGR of 9.6% from 2019 to 2026Over 110 startups working in the field of Onco-Immunotherapy were identifiedWith an increasing number of people with cancer (17 million of new cases of cancer worldwide) and the need of new treatments, the immunotherapy domain sees the arrival of numerous startups every year. In this highly diverse and rapidly changing ecosystem, it is crucial to identify new players and monitor their activities to determine opportunities, threats, potential partnerships and collaborations. Because of their small size and technological diversity, these young companies are hard to identify by conventional approaches (web searches, workshops etc.). In this report, the publisher has therefore investigated Onco-Immunotherapy-related patents in order to identify startups through their patent filings. More than 110 startups incorporated between 2010 and 2019 were thus identified, and for over 50 of them, the report describes their main activity, products, patents, and key people among their staff. This study reveals that Cell Adoptive Transfer (e.g. CAR-T cell) is by far the technology explored …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE